📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
43 announcements match the current filters (relevance ≥ 5).
Sanginita Chemicals to Acquire Agastya Green Energy & Raise ₹45 Cr via Preferential Issue
Sanginita Chemicals is diversifying into the renewable energy sector by acquiring 100% of Agastya Green Energy Limited (AGEL) through a share swap valued at ₹19.95 crore. Additionally, the company is raising ₹25 crore in cash by issuing shares to B N G Investment LLC at ₹13.05 per share. Post-allotment, B N G Investment LLC will become a majority shareholder with a 64.66% stake. AGEL is a newly incorporated entity with nil turnover, focusing on solar panel manufacturing and EPC services.
Key Highlights
Preferential issue of 1.53 crore shares for share swap and 1.92 crore shares for cash at ₹13.05 per share.
Total capital raise and acquisition value aggregates to approximately ₹45 crore.
B N G Investment LLC to hold 64.66% of the post-issue paid-up share capital.
Target entity AGEL and its subsidiaries are pre-revenue startups incorporated in March 2025.
Strategic shift from the chemical industry to the renewable energy and solar manufacturing value chain.
👀 What to Watch
Investors should closely monitor the massive equity dilution and the risks associated with diversifying into a pre-revenue solar business. The entry of a new majority shareholder suggests a significant change in the company's future strategic direction.
Sanginita Chemicals Board to Meet on March 20 for Preferential Issue; Trading Window Closed
Sanginita Chemicals Limited has announced a board meeting scheduled for March 20, 2026, to consider a proposal for raising funds through a preferential issue of equity shares. In accordance with SEBI regulations, the trading window for dealing in the company's shares has been closed effective March 17, 2026. The window will remain closed until 48 hours after the outcome of the board meeting is publicly disclosed. This move indicates a strategic intent to infuse capital, which will be subject to shareholder and regulatory approvals.
Key Highlights
Board meeting scheduled for March 20, 2026, to approve a preferential issue of equity shares.
Trading window for insiders closed from March 17, 2026, to prevent insider trading ahead of the news.
Trading restriction to be lifted 48 hours after the board meeting outcome is announced.
The proposed fundraise is subject to statutory, regulatory, and shareholder approvals.
👀 What to Watch
Investors should wait for the March 20 board meeting outcome to understand the scale of the fundraise and the identity of the participating investors. Monitor the issue price and potential equity dilution versus the growth prospects the new capital might provide.
Sanginita Chemicals Reports Q3 Net Loss of ₹2.78 Cr as Revenue Drops 29% YoY
Sanginita Chemicals reported a significant downturn in its Q3 FY26 performance, swinging to a net loss of ₹278.24 lakhs compared to a profit of ₹14.08 lakhs in the same quarter last year. Revenue from operations fell by approximately 29% YoY to ₹4,347.40 lakhs from ₹6,153.83 lakhs. The company's cumulative nine-month performance also shows a net loss of ₹335.24 lakhs, a sharp reversal from the ₹67.22 lakhs profit in the previous year's corresponding period. Operating expenses remained high relative to the shrinking top line, leading to a negative EPS of ₹1.07 for the quarter.
Key Highlights
Revenue from operations decreased 29.3% YoY to ₹4,347.40 lakhs from ₹6,153.83 lakhs.
Net loss for the quarter stood at ₹278.24 lakhs against a net profit of ₹14.08 lakhs in Q3 FY25.
Nine-month cumulative revenue dropped significantly to ₹13,348.64 lakhs from ₹17,982.87 lakhs YoY.
Earnings Per Share (EPS) turned negative at ₹(1.07) for the quarter compared to ₹0.05 in the previous year.
Total expenses for the quarter were ₹4,627.11 lakhs, which exceeded the total income of ₹4,347.81 lakhs.
👀 What to Watch
Investors should exercise caution as the company has transitioned into a loss-making phase with declining revenues. It is critical to monitor the company's ability to manage raw material costs and recover sales volumes in the upcoming quarters.
